People who eat fish and seafood containing high concentrations of mercury may be more likely to develop amyotrophic lateral sclerosis (ALS), a new preliminary study suggests. Researchers will present their study’s findings at the American Academy of Neurology’s 69th Annual Meeting, set for April 22-28 in Boston. The question isn’t whether people should…
Study Links Consumption of Fish, Seafood High in Mercury to ALS Risk
People who have amyotrophic lateral sclerosis (ALS) know how hard it can be to communicate, but a new app developed by Microsoft researchers, called GazeSpeak, may make speaking with the eyes a reality. GazeSpeak, to be unveiled in May at the Conference on Human Factors in Computing…
Researchers have developed a method to measure the effectiveness of a process of RNA destruction that clears abnormal molecules from cells. Since abnormally high production of junk RNA has been thought to contribute to amyotrophic lateral sclerosis (ALS), the method can be used to screen for drugs that may boost…
Eye Muscles Remain Unaffected by ALS Progression
Research into patients with amyotrophic lateral sclerosis (ALS) has found that the eye muscles are not affected by the disease that attacks all the other muscles in the body. Researchers focus on eye and limb muscles for clues about the disease. Read more here. The Swedish study found that even…
The fitness franchise Orangetheory Fitness has partnered with Augie’s Quest to raise $1 million over the next two weeks for amyotrophic lateral sclerosis (ALS) research. During the campaign (#IBurnForALS) — which lasts from February 20 to March 5 — more than 570 Orangetheory studios nationwide will encourage their members…
A recent study has found that low levels of vitamin D are linked to loss of movement in amyotrophic lateral sclerosis (ALS). However, lower levels of the vitamin were not to blame for the progression of symptoms. Learn more about the molecular changes in ALS in this video. In…
If parents pass on mutations in the C9orf72 gene, their children not only develop amyotrophic lateral sclerosis (ALS) or frontotemporal dementia but do so at an earlier age due to an expansion of the mutation. This finding makes it easier for physicians to determine when to start monitoring an individual carrying a C9orf72…
6 Foods That Can Help You Fight a Cold or Flu
Winter is a perilous time if you have a compromised immune system, but you can’t stay alone inside for four months. You have to get on with your daily life, and just hope you don’t succumb to other people’s bugs and illnesses. However, there are some foods that can help you avoid catching a cold…
Two French researchers, Martine Barkats and Maria-Grazia Biferi, are winners of the Avi Kremer ALS Treatment Prize, worth $1 million, for developing a gene therapy approach that shows promise in treating certain types of amyotrophic lateral sclerosis (ALS), Prize4Life announced in a recent press release. The approach targets one of the…
Neuraltus Pharmaceuticals has enrolled 50 of the 120 patients it hopes to obtain for a confirmatory Phase 2 clinical trial evaluating NP001 as a treatment for amyotrophic lateral sclerosis (ALS). Completion of enrollment is expected in mid-2017, with Neuraltus shooting for results in early 2018. Eighteen clinical sites across North…
Recent Posts
- Planting seeds of hope in life with ALS
- New European trial testing safety of ALS therapy targeting fat metabolism
- Nura raises $74M to support ALS trial, new nerve-protecting therapy
- Treatment burden affects nearly 70% of ALS patients in Italian study
- Lower levels of two molecules linked to faster ALS progression, shorter survival